Search

Simergent has developed the transformative FDA-approved Archimedes™ bloodless home dialysis system to enable far more kidney failure patients to treat at home.

Early detection of asthma attacks up to 20 days in advance using intelligent diagnostics + connected monitoring.

Invest 200 is a mission-driven fund building a $200M portfolio of certified sober homes: generate 10%+ cash flow and 25%+ IRR while housing people in recovery.

Mission: to preserve, protect and defend enterprises board members from fiduciary liability in a threatening cyber world.

SaveAdd is an intelligent execution layer for inventory decisions, turning surplus and at-risk stock into revenue, impact and operational intelligence.

AI weather agent for prediction markets

PittMoss has a patented manufacturing process that turns waste into agricultural substrates at a local level, disrupting the peat and mined substrate industry.

Wild Nectar Collection is a new kind of luxury travel company offering exceptional journeys rooted in trust and stewardship.

Microvascular Therapeutics is a clinical stage biopharma company pioneering in theranostics and ultrasound contrast agents.

Postpartum hemorrhage biomarker, alerting clinicians to unknown risk ahead of delivery, reducing incidents by 60% and cutting costs for health systems/payers.